Induction of cytotoxic T lymphocyte development from murine thymocytes by IL-1 and IL-6
- 30 April 1991
- journal article
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 26 (4) , 397-400
- https://doi.org/10.1016/0022-3468(91)90985-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer PatientsAnnals of Surgery, 1989
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- New Approaches to the Immunotherapy of Cancer Using Interleukin-2Annals of Internal Medicine, 1988
- Interleukin 6 is involved in interleukin 1‐induced activitiesEuropean Journal of Immunology, 1988
- B cell stimulatory factor 1 (interleukin 4) is sufficient for the proliferation and differentiation of lectin-stimulated cytolytic T lymphocyte precursors.The Journal of Experimental Medicine, 1987
- B cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T lymphocytes.The Journal of Experimental Medicine, 1987
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1Nature, 1985
- A differentiation factor required for the expression of cytotoxic T-cell functionNature, 1982